Axon Enterprise (NASDAQ:AXON – Get Free Report) had its price target increased by investment analysts at Northland Securities from $227.00 to $235.00 in a research note issued to investors on Friday, FlyOnTheWall reports. Northland Securities’ price target points to a potential upside of 12.38% from the stock’s current price.
Several other analysts have also recently issued reports on the company. TheStreet cut Axon Enterprise from a “b-” rating to a “c+” rating in a research note on Friday, May 26th. Barclays lowered their price objective on shares of Axon Enterprise from $256.00 to $239.00 and set an “overweight” rating for the company in a report on Wednesday. Credit Suisse Group raised their price objective on shares of Axon Enterprise from $300.00 to $309.00 in a report on Wednesday, May 10th. JPMorgan Chase & Co. upgraded shares of Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 price objective for the company in a report on Thursday, May 11th. Finally, Needham & Company LLC restated a “buy” rating and issued a $240.00 price objective on shares of Axon Enterprise in a report on Wednesday. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $237.91.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Trading Up 2.4 %
Shares of NASDAQ:AXON traded up $4.99 on Friday, reaching $209.11. 866,351 shares of the company traded hands, compared to its average volume of 927,736. The business’s 50-day simple moving average is $191.10 and its 200 day simple moving average is $202.80. Axon Enterprise has a 52 week low of $109.31 and a 52 week high of $229.95. The stock has a market capitalization of $15.63 billion, a P/E ratio of 156.02 and a beta of 0.88. The company has a current ratio of 3.38, a quick ratio of 2.97 and a debt-to-equity ratio of 0.47.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Tuesday, May 9th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.48. Axon Enterprise had a return on equity of 10.88% and a net margin of 7.24%. The firm had revenue of $343.04 million for the quarter, compared to analysts’ expectations of $312.07 million. As a group, equities analysts anticipate that Axon Enterprise will post 1.58 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CFO Brittany Bagley bought 250 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was acquired at an average price of $200.00 per share, with a total value of $50,000.00. Following the transaction, the chief financial officer now owns 109,174 shares in the company, valued at approximately $21,834,800. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Brittany Bagley purchased 250 shares of the firm’s stock in a transaction on Wednesday, May 17th. The shares were acquired at an average price of $200.00 per share, for a total transaction of $50,000.00. Following the purchase, the chief financial officer now directly owns 109,174 shares in the company, valued at $21,834,800. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 26,883 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $193.10, for a total transaction of $5,191,107.30. Following the completion of the sale, the president now owns 290,965 shares in the company, valued at approximately $56,185,341.50. The disclosure for this sale can be found here. In the last three months, insiders bought 45,250 shares of company stock worth $8,735,200 and sold 54,458 shares worth $10,534,340. 6.10% of the stock is owned by company insiders.
Hedge Funds Weigh In On Axon Enterprise
A number of hedge funds have recently added to or reduced their stakes in the stock. Jennison Associates LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at approximately $347,000. Versor Investments LP acquired a new stake in Axon Enterprise during the first quarter valued at $702,000. Meritage Portfolio Management acquired a new stake in Axon Enterprise during the fourth quarter valued at $249,000. Avantax Advisory Services Inc. grew its position in Axon Enterprise by 24.1% during the first quarter. Avantax Advisory Services Inc. now owns 2,344 shares of the biotechnology company’s stock valued at $527,000 after buying an additional 455 shares during the period. Finally, Advisor Group Holdings Inc. increased its stake in Axon Enterprise by 32.0% during the 4th quarter. Advisor Group Holdings Inc. now owns 32,121 shares of the biotechnology company’s stock worth $5,329,000 after buying an additional 7,780 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
